Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OrbiMed Advisors LLC

This article was originally published in Start Up

Executive Summary

Specialized funds permit an investment team to make use of expertise and contacts developed within a specific industry, but can often leave investors with no place to go when an entire sector goes south. Such is not the case with OrbiMed Advisors, however. While almost entirely focused on the pharmaceutical and biotech industries, OrbiMed's philosophy of investing along a continuum of drug discovery companies globally, from "two guys in a lab with a dream, to Pfizer," and on both the long and short sides of the market, has permitted it to profit during both market upturns and downdrafts.
Advertisement

Topics

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC090463

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel